@article{a1067df4c07447adb5a9f404aa4041ba,
title = "Cerebrospinal fluid findings in children with fever-associated status epilepticus: Results of the consequences of prolonged febrile seizures (FEBSTAT) study",
abstract = "This prospective multicenter study of 200 patients with fever-associated status epilepticus (FSE), of whom 136 underwent a nontraumatic lumbar puncture, confirms that FSE rarely causes cerebrospinal fluid (CSF) pleocytosis. CSF glucose and protein levels were unremarkable. Temperature, age, seizure focality, and seizure duration did not affect results. CSF pleocytosis should not be attributed to FSE.",
keywords = "CNS, CSF, Central nervous system, Cerebrospinal fluid, FSE, Fever-associated status epilepticus, LP, Lumbar puncture, WBC, White blood cell",
author = "Frank, {L. Matthew} and Shlomo Shinnar and Hesdorffer, {Dale C.} and Shinnar, {Ruth C.} and Pellock, {John M.} and William Gallentine and Nordli, {Douglas R.} and Epstein, {Leon G.} and Mosh{\'e}, {Solomon L.} and Lewis, {Darrell V.} and Shumei Sun",
note = "Funding Information: J.P. is funded by grants from the NIH (NS043209 and NS045911) and CDC. He has also received research support from Eisai, Marinus, Lundbeck, Pfizer, Questcor, and UCB. He has received compensation for serving on Scientific Advisory Boards for Eisai, Lundbeck, Questcor, Sepracor, and UCB. He has been a consultant for Catalyst, Eisai, GlaxoSmithKline, King, KV Pharmaceuticals, Lundbeck, Marinus, Neuropace, Pfizer, Questcor, Sepracor, Sunovion, UCB, Upsher Smith, and Valeant. All grants, research support, consultant fees, and honoraria are paid to Virginia Commonwealth University or the physician practice plan (MCV Physicians). Funding Information: S.Sh. is funded by the NIH (NS 43209, NS 045911, NS 053998, NS 066929, 1U10NS077308, and UL1 RR025759), serves on the Editorial Board of Pediatric Neurology, serves on a data safety monitoring board (DSMB) for King Pharmaceuticals, has received personal compensation for serving on Scientific Advisory Boards for Questcor and Sunovion and consulting for Eisai, Questcor, and Neuronex, and has received speaker honoraria from Eisai, Questcor, and UCB. He has also given expert testimony in medicolegal cases. Funding Information: S.Su. is funded by the NIH (1R01HD060913, 7R01DK071485, 1U01HL101064, 1UL1RR031990, R01HD038356, 2R01HL040619, and R01NS043209), and she serves as a consultant for Nestle. Funding Information: Supported by NINDS “Consequences of Prolonged Febrile Seizures” (FEBSTAT) (NS 43209 to FEBSTAT; PI: S.Sh.). Funding and conflicts of interest are available at www.jpeds.com ( Appendix 2 ). Funding Information: S.M. is funded by grants from the NIH (NS43209, NS20253, and NS45911) and the Heffer Family Foundation. He is serving as Associate Editor of Neurobiology of Disease and is on the Editorial Board of Epileptic Disorders, Brain and Development, Pediatric Neurology, and Physiological Research. He receives annual compensation from Elsevier for his work as Associate Editor in Neurobiology of Disease and royalties from two books that he co-edited. He received a consultant fee from Eisai and a speaker's fee and travel expenses from GlaxoSmithKline. Funding Information: D.H. is funded by grants from the NIH (NS043209, NS31146, NS078419, 5U01NS04911, HD042823), Centers for Disease Control and Prevention (CDC; DP002209 and MM1002), Association of University Centers on Disabilities (RT01), Maternal and Child Health Bureau (MC00007), and the Epilepsy Study Consortium and Epilepsy Foundation of America. She has served on the Editorial Boards of Epilepsia (2008-2011) and is currently on the Editorial Boards of Epilepsy Research and Epilepsy and Behavior, as well as a Contributing Editor to Epilepsy Currents. She is a consultant to Mt Sinai Medical Center, New York, and has a received a travel grant award from GlaxoSmithKline. ",
year = "2012",
month = dec,
doi = "10.1016/j.jpeds.2012.08.008",
language = "English (US)",
volume = "161",
pages = "1169--1171.e1",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6",
}